论文部分内容阅读
对１８例肝癌患者采用靛青绿（ＩＣＧ）注射液静脉注射，不同时间采血，用分光光度计测量ＩＣＧ在肝脏的潴留率及清除率。结果表明肝癌组和对照组ＩＣＧ血浆潴留率Ｘ±ｓ为４０．２２％±６．４２％，６．３８％±１．４５％，血浆清除率Ｘ±ｓ为０．０５％±０．０３％，０．１９％±０．０２％，Ｐ＜０．０１。两组差异有高度显著性。而且，肝癌患者的血浆白蛋白≤２９ｇ／Ｌ组的潴留率高于血浆白蛋白≥３０ｇ／Ｌ组（７５．００％±２２．７５％，３５．８５％±７．００％，Ｐ＜０．０５）。ＩＣＧ滞留试验可以较真实反映肝癌患者的肝脏功能。
Eighteen cases of liver cancer patients were treated with intravenous injection of indocyanine green (ICG) injection, blood was collected at different times, and the retention rate and clearance rate of ICG in the liver were measured with a spectrophotometer. The results showed that the plasma retention rate of ICG in the liver cancer group and the control group was 40.22%±6.42%, 6.38%±1.45%, and the plasma clearance rate was ±0.05%. %, 0.19%±0.02%, P<0.01. The difference between the two groups was highly significant. Moreover, the retention rate of plasma albumin ≤29g/L group in liver cancer patients was higher than that of plasma albumin ≥30g/L group (75.00%±22.75%, 35.85%±7.00%, P<0 .05). The ICG retention test can truly reflect the liver function of liver cancer patients.